How CNS Pediatric Clinical Development is Evolving

Clinical research was forced to adapt during the recent coronavirus pandemic, and pediatric CNS studies were no different. The changes made for safety and efficacy assessments are discussed as well as how CNS studies were gradually opened again, and learnings that should be applied going forward. This CNS Summit largely served as an open discussion for industry members to describe their personal COVID-19 experiences and how clinical trial research will be forever changed. Signant Health’s Joan Busner speaks on how the company works with sponsors and sites to digitally enable studies.